Cover Image

A Multi-Centre Prospective Study of the Efficacy and Safety of Alglucosidase Alfa in Chinese Patients With Infantile-Onset Pompe Disease

Background: A high prevalence of infantile-onset Pompe disease (IOPD) in the Chinese population has been noted, but there are currently no reported clinical trials of enzyme replacement therapy (ERT) for IOPD in this population. The purpose of this study was to evaluate the efficacy and safety of al...

Full description

Saved in:

Bibliographic Details
Main Authors:	Diqi Zhu (Author), Jiacong Zhu (Author), Wenjuan Qiu (Author), Benzhen Wang (Author), Lin Liu (Author), Xiaodan Yu (Author), Zhenheng Ou (Author), Guangsong Shan (Author), Jian Wang (Author), Bin Li (Author), Xiaokang Chen (Author), Cong Liu (Author), Zipu Li (Author), Lijun Fu (Author)
Format:	Book
Published:	Frontiers Media S.A., 2022-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Alglucosidase alfa: Long term use in the treatment of patients with Pompe disease
by: Michael Beck
Published: (2009)

ALGLUCOSIDASE ALFA - A NEW STAGE IN THE THERAPY OF INFANTILE POMPE DISEASE
by: E. N. Basargina, et al.
Published: (2014)

Efficacy and safety of enzyme replacement therapy with alglucosidase alfa for the treatment of patients with infantile-onset Pompe disease: a systematic review and metanalysis
by: A. D. Dornelles, et al.
Published: (2024)

Immune responses to alglucosidase in infantile Pompe disease: recommendations from an Italian pediatric expert panel
by: Vincenza Gragnaniello, et al.
Published: (2022)

Case Report: Two Chinese Infants of Sengers Syndrome Caused by Mutations in AGK Gene
by: Benzhen Wang, et al.
Published: (2021)

Arrhythmia and/or Cardiomyopathy Related to Maternal Autoantibodies: Descriptive Analysis of a Series of 16 Cases From a Single Center
by: Benzhen Wang, et al.
Published: (2019)

Switching treatment to cipaglucosidase alfa plus miglustat positively affects patient-reported outcome measures in patients with late-onset Pompe disease
by: Priya S. Kishnani, et al.
Published: (2024)

Tratamento da Doença de Pompe - deficiência da alfa-glicosidase ácida
by: Micaela Inês KUHN, et al.
Published: (2014)

Improved Enzyme Replacement Therapy with Cipaglucosidase Alfa/Miglustat in Infantile Pompe Disease
by: Lina Fiege, et al.
Published: (2023)

Comparing the efficacy of cipaglucosidase alfa plus miglustat with other enzyme replacement therapies for late-onset Pompe disease: a network meta-analysis utilizing patient-level and aggregate data
by: Simon Shohet, et al.
Published: (2024)

Lapatinib, trastuzumab or the combination added to neoadjuvant chemotherapy for breast cancer
by: Quan Liang, et al.
Published: (2016)

The infantile-onset form of Pompe disease: an autopsy diagnosis
by: Otávio César Cruz dos Santos
Published: (2015)

Infantile Pompe disease with intrauterine onset: a case report and literature review
by: Hongmin Xi, et al.
Published: (2022)

The impact of general anesthesia on the outcomes of preterm infants with gestational age less than 32 weeks delivered via cesarean section
by: Lijun Wang, et al.
Published: (2024)

Social-economic burden of Pompe disease with late onset in the Russian Federation
by: A. S. Kolbin, et al.
Published: (2019)

Late-onset Pompe disease - literature review and summary of current knowledge
by: Karolina Jaskuła, et al.
Published: (2023)

A genetic disease under the multiform mask - infantile-onset of Pompe disease
by: Klaudia Jadczak, et al.
Published: (2024)

The Timely Needs for Infantile Onset Pompe Disease Newborn Screening-Practice in Taiwan
by: Shu-Chuan Chiang, et al.
Published: (2020)

Expression of markers of endoplasmic reticulum stress-induced apoptosis in the placenta of women with early and late onset severe pre-eclampsia
by: Jinhua Fu, et al.
Published: (2015)

Monitoramento do Uso da Alfa-Alglicosidase para o Tratamento da Doença de Pompe Após Incorporação ao SUS
by: Mariá Gonçalves Pereira Silva, et al.
Published: (2023)

A Newborn Screening, Presymptomatically Identified Infant With Late-Onset Pompe Disease: Case Report, Parental Experience, and Recommendations
by: Raymond Y. Wang
Published: (2020)

Clinical course, mutations and its functional characteristics of infantile-onset Pompe disease in Thailand
by: Lukana Ngiwsara, et al.
Published: (2019)

Population Pharmacokinetics of Ropeginterferon Alfa-2b: A Comparison Between Healthy Caucasian and Chinese Subjects
by: Min Zhu, et al.
Published: (2021)

The Pomp of Yesterday
by: Hocking, Joseph, 1860-1937

Base editing rescues acid α-glucosidase function in infantile-onset Pompe disease patient-derived cells
by: Chloe L. Christensen, et al.
Published: (2024)

Infantile-onset Pompe disease complicated by sickle cell anemia: Case report and management considerations
by: Rodrigo Tzovenos Starosta, et al.
Published: (2022)

Importance of Timely Treatment Initiation in Infantile-Onset Pompe Disease, a Single-Centre Experience
by: Javier de las Heras, et al.
Published: (2021)

The Protective Effects of Danggui-Baizhu-Tang on High-Fat Diet-Induced Obesity in Mice by Activating Thermogenesis
by: Lijun Zhao, et al.
Published: (2018)

The Pomp of the Lavilettes, Complete
by: Parker, Gilbert, 1862-1932

From the hypertransaminasemia symptoms to the recognition of late-onset Pompe disease in a 12-year-old boy
by: Ewa Grzywna, et al.
Published: (2021)

Infantile-onset pompe disease: a case report emphasizing the role of genetic counseling and prenatal testing
by: Yasaman Alizadeh, et al.
Published: (2024)

Treatment of infantile-onset Pompe disease in a rat model with muscle-directed AAV gene therapy
by: Sergio Muñoz, et al.
Published: (2024)

Retrospective analysis of prenatal ultrasound of children with Pompe disease
by: Yan-Lin Li, et al.
Published: (2022)

Relato do primeiro paciente brasileiro com a forma infantil da doença de Pompe tratado com alfa-glicosidase recombinante humana Report of the first Brazilian infantile Pompe disease patient to be treated with recombinant human acid alpha-glucosidase
by: Sandra J. Pereira, et al.
Published: (2008)

Correction to: A cross-sectional study on the correlation between cytokines in a pelvic environment and tubal factor infertility
by: Jiacong Yan, et al.
Published: (2021)

A cross-sectional study on the correlation between cytokines in a pelvic environment and tubal factor infertility
by: Jiacong Yan, et al.
Published: (2020)

CD19+CD1dhiCD5hi B Cells Can Downregulate Malaria ITV Protection by IL-10 Secretion
by: Hongli Guan, et al.
Published: (2020)

Use of the patient-reported outcomes measurement information system (PROMIS®) to assess late-onset Pompe disease severity
by: Melodi Harfouche, et al.
Published: (2020)

Pompe disease, a late-onset - misleading form of diagnosis in a patient with persistent hepatic cytolysis syndrome
by: Smaranda Diaconescu, et al.
Published: (2020)

A Qualitative Study: Mothers' Experiences of Their Child's Late-Onset Pompe Disease Diagnosis Following Newborn Screening
by: Kaylee Crossen, et al.
Published: (2022)